| Written | 2007-11 | Deborah J Stumpo, Perry J Blackshear |
| Laboratory of Neurobiology, NIEHS MD A2-05, 111 Alexander Drive, Research Triangle Park, NC 27709, USA |
| Identity |
| Alias_names | BRF1 |
| zinc finger protein, C3H type, 36-like 1 | |
| zinc finger protein 36, C3H type-like 1 | |
| Alias_symbol (synonym) | RNF162B |
| Berg36 | |
| ERF1 | |
| TIS11B | |
| cMG1 | |
| Other alias | |
| HGNC (Hugo) | ZFP36L1 |
| LocusID (NCBI) | 677 |
| Atlas_Id | 42866 |
| Location | 14q24.1 [Link to chromosome band 14q24] |
| Location_base_pair | Starts at 68787655 and ends at 68793914 bp from pter ( according to hg19-Feb_2009) [Mapping ZFP36L1.png] |
| Fusion genes (updated 2017) | Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands) |
| CRIPT (2p21) / ZFP36L1 (14q24.1) | TTC26 (7q34) / ZFP36L1 (14q24.1) | ZFP36L1 (14q24.1) / EHD1 (11q13.1) | |
| ZFP36L1 (14q24.1) / FGB (4q31.3) | ZFP36L1 (14q24.1) / LARGE1 (22q12.3) | ZFP36L1 (14q24.1) / MICU2 (13q12.11) | |
| ZFP36L1 (14q24.1) / SMG6 (17p13.3) | ZFP36L1 (14q24.1) / TMED9 (5q35.3) |
| Note | The rat clone of ZFP36L1, cMG1, was the first cloned member of the tristetraprolin (TTP, TIS11, NUP475, GOS24) family of CCCH tandem zinc finger proteins. There are 4 mammalian members of this family, TTP, ZFP36L1, ZFP36L2 (TIS11D, ERF2, BRF2), and ZFP36L3. ZFP36L3 is the only family member that is rodent-specific. These proteins have been shown to bind (via their conserved tandem zinc finger domain) directly to class II AU-rich elements (ARE) in the 3'-untranslated region (UTR) of mRNA leading to deadenylation and destabilization of the mRNA. |
| DNA/RNA |
 | |
| Diagram of the human ZFP36L1 gene. Exons are represented by gray boxes; intron by the hatched box. The translation start site is indicated by the arrow and the translation stop site by the double line. The dark box represents the CCCH tandem zinc finger domain. | |
| Description | The human ZFP36L1 has 2 exons spanning 5411 bp on chromosome 14 (NC_000014.7; NT_026437.11). The first exon, which is small (186 bp), is separated from the larger second exon (2834 bp) by a 2388 bp intron. |
| Transcription | 3022 bp human transcript (NM_004926.2) with 1014 bp (338 amino acids) of coding region. |
| Pseudogene | None known. |
| Protein |
| Description | Human ZFP36L1 is a 338 amino acid protein with a predicted molecular weight of 36.3 kDa. |
| Expression | In the adult mouse, expression appears to be ubiquitous. Based on northern blots, mRNA expression is highest in mouse kidney, spleen, ovary and lung, with lower levels of expression in thymus and heart, and still lower levels in brain, liver and testis. In the embryonic mouse, mRNA was barely detectable at embryonic day 7.5 (E7.5), but increased dramatically by E9.5 and E10.5. In situ hybridization histochemistry demonstrated that there was high level expression in the allantois at E8.0, immediately before fusion with the chorion. Expression is also seen in mouse embryonic stem cells. |
| Localisation | Transfection studies using a GFP-tagged protein have shown diffuse cytoplasmic expression. There is good evidence that the protein can shuttle between the nucleus and the cytoplasm in a CRM1 (nuclear export receptor)-dependent, leptomycin B-inhibitable manner. |
| Function | ZFP36L1 is a member of the TTP (ZFP36) family of CCCH tandem zinc finger proteins. These proteins have been shown to bind to target mRNAs through their AU-rich elements present in the 3'-untranslated regions of the mRNA. The binding of these proteins to mRNA leads to deadenylation and destabilization of the mRNA. All four family members have been shown to bind directly to single stranded RNA probes (RNA gel shift assays), destabilize target mRNA (co-transfection assays), and deadenylate ARE-containing RNA probes (cell-free deadenylation assays). Physiological target mRNAs have been identified for TTP which include tumor necrosis factor alpha (TNF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-2b (IL-2), and immediate early response gene 3 (IER3, IEX-1, gly96). To date, one physiological target mRNA has been identified for ZFP36L1; however, this target mRNA is not destabilized by ZFP36L1 (see below). Two reports of ZFP36L1 knockout mice have been published. In one report, knockout embryos died around embryonic day 11 mainly due to failure of chorioallantoic fusion. When fusion did occur, there was increased apoptosis throughout the neural tube, as well as placental failure due to atrophy of the trophoblast layers. In a second report, knockout embryos also died at mid-gestation and exhibited extraembryonic and intraembryonic vascular abnormalities and heart defects. In the developing placenta, the extraembryonic mesoderm failed to invaginate the trophoblast layer. This phenotype was associated with an elevated expression of vascular endothelial growth factor (VEGF)-A (in the embryo and in mouse embryonic fibroblasts). This elevated level of expression was not due to increased stability of the VEGF-A mRNA, but rather due to enhanced association with polyribosomes. This is in contrast to a prior report using co-transfection studies showing that ZFP36L1 was able to bind to two AU-rich motifs in the 3' UTR of VEGF mRNA that led to destabilization of the mRNA. Mouse ZFP36L1 has been shown to interact with 14-3-3 proteins in a phosphorylation-dependent manner. This interaction causes ZFP36L1 to be sequestered in the cytoplasm preventing it from regulating mRNA decay. Several studies have suggested that ZFP36L1 may function as a pro-apoptotic protein. |
| Homology | Four members of the TTP family of CCCH tandem zinc finger proteins, TTP (ZFP36), ZFP36L1, ZFP36L2 and the rodent-specific ZFP36L3, have been identified. They all share a highly conserved tandem zinc finger domain. |
| Mutations |
| Note | Eight polymorphisms have been identified. The functional significance of these polymorphisms has not been determined. 1) G change into T at base 644 in the 5' UTR 2) AG change into GC at base 706 in the first coding region 3) G change into A at base 729 in the intron 4) C change into CC at base 772 in the intron 5) A change into G at base 804 in the intron 6) G change into C at base 845 in the intron 7) G change into A at base 3685 in the second coding region 8) C change into A at base 3915 in the second coding region |
| Implicated in |
| Note | |
| Entity | Cisplatin sensitivity in head and neck squamous cell carcinoma (HNSCC). |
| Note | A common feature in HNSCC is cisplatin sensitivity. Microarray analysis identified mouse ZFP36L1 to be differentially expressed by cisplatin treatment. Cisplatin-sensitive HNSCC cell lines expressed elevated levels of ZFP36L1 compared to cisplatin-resistant HNSCC cell lines. Downregulation of ZFP36L1 (using antisense oligonucleotides) in cisplatin-sensitive cell lines made the cells cisplatin-resistant. Conversely, overexpression of ZFP36L1 reverted cisplatin-resistant cells to cisplatin-sensitive cells. There was an inverse correlation between the expression levels of ZFP36L1 and the human inhibitor of apoptosis protein-2, cIAP2 (Birc3, baculoviral IAP repeat-containing 3). Increased expression of ZFP36L1 also correlated with increased caspase-3 activity and increased cisplatin-induced apoptosis. These results suggested that expression of ZFP36L1 enhanced cisplatin sensitivity in HNSCC cells by reducing cIAP2 mRNA levels. |
| Entity | t(8;21) translocation |
| Note | The AML1-MTG8 fusion transcription factor generated by t(8;21) translocation is thought to affect the normal regulation of genes that are needed for differentiation and proliferation of hematopoietic progenitors leading to acute myelogenous leukemia (AML). ZFP36L1 was identified as an up-regulated gene in t(8;21) leukemic cells suggesting that it may be important to AML1-MTG8-mediated leukemogenesis. |
| Entity | Human T-lymphotropic virus 1(HTLV-1) |
| Note | ZFP36L1 expression is also up-regulated in human T-lymphotropic virus 1(HTLV-1)-infected cells. HTLV-1 is associated with adult T-cell leukemia/lymphoma and the Tax oncoprotein encoded by the 3' region of HTLV-1 has been proposed to dysregulate the expression of many genes that are important for cell proliferation. The Tax transactivator was shown to bind to two ZFP36L1 upstream elements (a novel transcription factor-binding site labeled BRF1 Tax-responsive site or BTRS and a second consensus cAMP-responsive site or CRE). |
| Entity | Various cancers. |
| Note | Increased expression of ZFP36L1 has been seen in several cancers including lymph node (+) primary breast tumors and hepatocellular carcinomas. Increased expression has also been demonstrated in a number of the NCI 60 panel of human cancer cell lines. These include the mammary gland cancer cell lines BT549, MDA-MB-231, and NCI/ADR-RES; ovarian cell lines OVCAR-5, OVCAR-8 and SK-OV-3; lung cell line NCI-H226; skin cell lines LOXMVI, M14, MALME-3M, and SK-MEL-2; brain cell lines SF268 and SF295; prostate cell line PC-3; kidney cell lines A498, ACHN, CAKI-1, SN12C, TK10, and UO31; and colon cell line HT29. |
| Bibliography |
| Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. |
| Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM |
| Molecular cancer research : MCR. 2007 ; 5 (9) : 881-890. |
| PMID 17855657 |
| The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. |
| Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR, Turner M |
| Developmental dynamics : an official publication of the American Association of Anatomists. 2006 ; 235 (11) : 3144-3155. |
| PMID 17013884 |
| BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. |
| Benjamin D, Schmidlin M, Min L, Gross B, Moroni C |
| Molecular and cellular biology. 2006 ; 26 (24) : 9497-9507. |
| PMID 17030608 |
| Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. |
| Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Richfield EK, Lai WS |
| Biology of reproduction. 2005 ; 73 (2) : 297-307. |
| PMID 15814898 |
| The product of the primary response gene BRF1 inhibits the interaction between 14-3-3 proteins and cRaf-1 in the yeast trihybrid system. |
| Bustin SA, McKay IA |
| DNA and cell biology. 1999 ; 18 (8) : 653-661. |
| PMID 10463061 |
| Cloning and characterization of ERF-1, a human member of the Tis11 family of early-response genes. |
| Bustin SA, Nie XF, Barnard RC, Kumar V, Pascall JC, Brown KD, Leigh IM, Williams NS, McKay IA |
| DNA and cell biology. 1994 ; 13 (5) : 449-459. |
| PMID 8024689 |
| Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. |
| Carballo E, Lai WS, Blackshear PJ |
| Blood. 2000 ; 95 (6) : 1891-1899. |
| PMID 10706852 |
| Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. |
| Carrick DM, Blackshear PJ |
| Archives of biochemistry and biophysics. 2007 ; 462 (2) : 278-285. |
| PMID 17517366 |
| Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. |
| Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ |
| Oncogene. 2004 ; 23 (53) : 8673-8680. |
| PMID 15467755 |
| Identification of a mRNA rapidly induced in an intestinal epithelial cell line by epidermal growth factor. |
| Gomperts M, Pascall JC, Brown KD |
| Biochemical Society transactions. 1990 ; 18 (4) : 568-569. |
| PMID 2276442 |
| Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. |
| Johnson BA, Stehn JR, Yaffe MB, Blackwell TK |
| The Journal of biological chemistry. 2002 ; 277 (20) : 18029-18036. |
| PMID 11886850 |
| Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. |
| Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ |
| The Journal of biological chemistry. 2000 ; 275 (23) : 17827-17837. |
| PMID 10751406 |
| Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. |
| Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ |
| Molecular and cellular biology. 2006 ; 26 (24) : 9196-9208. |
| PMID 17030620 |
| Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines. |
| Lee SK, Kim SB, Kim JS, Moon CH, Han MS, Lee BJ, Chung DK, Min YJ, Park JH, Choi DH, Cho HR, Park SK, Park JW |
| International journal of cancer. Journal international du cancer. 2005 ; 117 (1) : 32-40. |
| PMID 15880358 |
| Expression of butyrate response factor 1 in HTLV-1-transformed cells and its transactivation by tax protein. |
| Li B, Fink T, Ebbesen P, Liu XD, Zachar V |
| Archives of virology. 2003 ; 148 (9) : 1787-1804. |
| PMID 14505090 |
| Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36. |
| Ning ZQ, Norton JD, Li J, Murphy JJ |
| European journal of immunology. 1996 ; 26 (10) : 2356-2363. |
| PMID 8898945 |
| Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. |
| Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR |
| Journal of immunology (Baltimore, Md. : 1950). 2005 ; 174 (2) : 953-961. |
| PMID 15634918 |
| Members of the tristetraprolin family of tandem CCCH zinc finger proteins exhibit CRM1-dependent nucleocytoplasmic shuttling. |
| Phillips RS, Ramos SB, Blackshear PJ |
| The Journal of biological chemistry. 2002 ; 277 (13) : 11606-11613. |
| PMID 11796723 |
| Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. |
| Shimada H, Ichikawa H, Nakamura S, Katsu R, Iwasa M, Kitabayashi I, Ohki M |
| Blood. 2000 ; 96 (2) : 655-663. |
| PMID 10887131 |
| Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. |
| Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, Meyers EN, Mishina Y, Blackshear PJ |
| Molecular and cellular biology. 2004 ; 24 (14) : 6445-6455. |
| PMID 15226444 |
| The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. |
| Varnum BC, Ma QF, Chi TH, Fletcher B, Herschman HR |
| Molecular and cellular biology. 1991 ; 11 (3) : 1754-1758. |
| PMID 1996120 |
| Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis. |
| Zindy PJ, L'Helgoualc'h A, Bonnier D, Le Béchec A, Bourd-Boitin K, Zhang CX, Musso O, Glaise D, Troadec MB, Loréal O, Turlin B, Léger J, Clément B, Théret N |
| Hepatology (Baltimore, Md.). 2006 ; 44 (5) : 1296-1307. |
| PMID 17058241 |
| Citation |
| This paper should be referenced as such : |
| Stumpo, DJ ; Blackshear, PJ |
| ZFP36L1 (zinc finger protein 36, C3H type-like 1) |
| Atlas Genet Cytogenet Oncol Haematol. 2008;12(4):296-298. |
| Free journal version : [ pdf ] [ DOI ] |
| On line version : http://AtlasGeneticsOncology.org/Genes/ZFP36L1ID42866ch14q22.html |
| Other Leukemias implicated (Data extracted from papers in the Atlas) [ 3 ] |
|
del(14)(q24q32) ZFP36L1/IGH
t(1;14)(p34;q24) SFPQ/ZFP36L1 t(11;14)(q13;q24) ZFP36L1/EHD1 |
| External links |
| REVIEW articles | automatic search in PubMed |
| Last year publications | automatic search in PubMed |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Thu Jan 17 19:12:23 CET 2019 |
For comments and suggestions or contributions, please contact us